Carregant...

Ethical challenges with the left ventricular assist device as a destination therapy

The left ventricular assist device was originally designed to be surgically implanted as a bridge to transplantation for patients with chronic end-stage heart failure. On the basis of the REMATCH trial, the US Food and Drug Administration and the US Centers for Medicare & Medicaid Services appro...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Rizzieri, Aaron G, Verheijde, Joseph L, Rady, Mohamed Y, McGregor, Joan L
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2008
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2527574/
https://ncbi.nlm.nih.gov/pubmed/18694496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1747-5341-3-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!